Debate: Optimal chemotherapy backbone for targeted agents in pancreatic cancer? - FOLFIRINOX

Debate: Optimal chemotherapy backbone for targeted agents in pancreatic cancer? - FOLFIRINOX

User Photo
HMP CME

4 years
413 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
In this presentation from "Great Debates and Updates in GI Malignancies 2016", Dr. Howard S. Hochster argues that FOLFIRINOX is the optimal chemotherapy backbone for targeted agents in pancreatic cancer. A continuing education program is offered as a supplement to this webcast at the following location: http://elc.imedex.com/ELC/Activity-Search.aspx?search=7205 © 2016 Imedex, LLC.
Up Next Autoplay